ERBB2 and invasive breast carcinoma: BrCa is a heterogenic disease that can be categorized into four main molecular distinct subtypes based on gene expression profiling: luminal A, luminal B, human epithelial growth factor receptor-2 (HER-2) overexpressing and basal/triple negative (TN) cancer subtype [2-5] (Figure 1).